ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,584.54
      -0.88%
      US Tech 100
      19,659.60
      -2.28%
      Dow Jones
      39,753.75
      0.08%
      Brent Oil
      85.105
      -0.01%
      Bitcoin
      56,905.49
      -0.78%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. TCR2 Therapeutics Inc (TCRR)

      7. TCR2 Therapeutics Inc (TCRR) News

      TCRR

      TCR2 Therapeutics (TCRR)

      TCR2 Therapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:TCRR
      DateTimeSourceHeadlineSymbolCompany
      12:21PMiHub NewswireFeaturedCannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing
      08/26/20224:32PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TCRRTCR2 Therapeutics Inc
      08/18/20226:15AMTipRanksH.C. Wainwright Sticks to Their Buy Rating for TCR2 Therapeutics (TCRR)NASDAQ:TCRRTCR2 Therapeutics Inc
      08/11/20222:21AMTipRanksAnalysts Offer Insights on Healthcare Companies: NeoGenomics (NEO), TCR2 Therapeutics (TCRR) and Babylon (BBLN)NASDAQ:TCRRTCR2 Therapeutics Inc
      08/08/20221:25PMTipRanksMizuho Securities Reaffirms Their Buy Rating on TCR2 Therapeutics (TCRR)NASDAQ:TCRRTCR2 Therapeutics Inc
      08/08/20227:17AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:TCRRTCR2 Therapeutics Inc
      08/08/20227:01AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TCRRTCR2 Therapeutics Inc
      08/08/20226:45AMGlobeNewswire Inc.TCR² Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate UpdateNASDAQ:TCRRTCR2 Therapeutics Inc
      08/01/20225:15PMGlobeNewswire Inc.TCR² Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:TCRRTCR2 Therapeutics Inc
      07/11/20228:05PMTipRanksMizuho Securities Thinks TCR2 Therapeutics’ Stock is Going to RecoverNASDAQ:TCRRTCR2 Therapeutics Inc
      07/08/20224:59PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:TCRRTCR2 Therapeutics Inc
      07/01/20224:15PMGlobeNewswire Inc.TCR² Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:TCRRTCR2 Therapeutics Inc
      06/27/20225:13PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:TCRRTCR2 Therapeutics Inc
      06/27/20226:45AMGlobeNewswire Inc.TCR² Therapeutics Appoints Industry and Finance Veteran Eric Sullivan as Chief Financial OfficerNASDAQ:TCRRTCR2 Therapeutics Inc
      06/01/20224:20PMGlobeNewswire Inc.TCR² Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:TCRRTCR2 Therapeutics Inc
      06/01/20226:45AMGlobeNewswire Inc.TCR² Therapeutics to Participate in Two Upcoming Conferences in JuneNASDAQ:TCRRTCR2 Therapeutics Inc
      05/19/20226:15AMTipRanksAnalysts Offer Insights on Healthcare Companies: EDAP TMS (EDAP) and TCR2 Therapeutics (TCRR)NASDAQ:TCRRTCR2 Therapeutics Inc
      05/14/202212:22AMTipRanksTCR2 Therapeutics (TCRR) Gets a Hold Rating from SVB SecuritiesNASDAQ:TCRRTCR2 Therapeutics Inc
      05/12/20221:05PMTipRanksTCR2 Therapeutics (TCRR) Initiated with a Buy at Mizuho SecuritiesNASDAQ:TCRRTCR2 Therapeutics Inc
      05/12/20227:02AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TCRRTCR2 Therapeutics Inc
      05/12/20226:45AMGlobeNewswire Inc.TCR² Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate UpdateNASDAQ:TCRRTCR2 Therapeutics Inc
      05/02/20225:32PMGlobeNewswire Inc.TCR² Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:TCRRTCR2 Therapeutics Inc
      04/10/20229:35PMTipRanksMizuho Securities Thinks TCR2 Therapeutics’ Stock is Going to RecoverNASDAQ:TCRRTCR2 Therapeutics Inc
      04/01/20224:15PMGlobeNewswire Inc.TCR² Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:TCRRTCR2 Therapeutics Inc
      03/24/20226:05AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:TCRRTCR2 Therapeutics Inc
      03/22/20224:45PMEdgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:TCRRTCR2 Therapeutics Inc
      03/22/20224:07PMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:TCRRTCR2 Therapeutics Inc
      03/22/202212:15PMTipRanksTCR2 Therapeutics (TCRR) Gets a Buy Rating from Mizuho SecuritiesNASDAQ:TCRRTCR2 Therapeutics Inc
      03/22/20227:48AMEdgar (US Regulatory)Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr)NASDAQ:TCRRTCR2 Therapeutics Inc
      03/22/20226:45AMGlobeNewswire Inc.TCR² Therapeutics Reports Fourth Quarter 2021 Financial Results and Provides Corporate UpdateNASDAQ:TCRRTCR2 Therapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:TCRR

      Your Recent History

      TG
      ENL
      Enel
      Delayed Upgrade Clock